title: Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type I.
authors.affiliation: Department of Internal Medicine, Baylor University Medical Center, Dallas 75246, USA.
authors.forename: C
authors.initials: C
authors.lastname: Högenauer
authors.forename: R L
authors.initials: RL
authors.lastname: Meyer
authors.forename: G J
authors.initials: GJ
authors.lastname: Netto
authors.forename: D
authors.initials: D
authors.lastname: Bell
authors.forename: K H
authors.initials: KH
authors.lastname: Little
authors.forename: L
authors.initials: L
authors.lastname: Ferries
authors.forename: C A
authors.initials: CA
authors.lastname: Santa Ana
authors.forename: J L
authors.initials: JL
authors.lastname: Porter
authors.forename: J S
authors.initials: JS
authors.lastname: Fordtran
mesh_terms: D001706:Biopsy; D002766:Cholecystokinin / Q000097:blood / Q000172:deficiency*; D004386:Duodenum / Q000166:cytology* / Q000473:pathology; D019858:Enteroendocrine Cells / Q000378:metabolism; D005749:Gastric Inhibitory Polypeptide / Q000097:blood; D006801:Humans; D008286:Malabsorption Syndromes / Q000209:etiology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D019894:Peptide YY / Q000097:blood; D016884:Polyendocrinopathies, Autoimmune / Q000150:complications* / Q000188:drug therapy
chemical_list: D019894:Peptide YY; D005749:Gastric Inhibitory Polypeptide; D002766:Cholecystokinin